Applications
Analgesics on Synergi Polar-RP
14250
Separation Mode: Reversed Phase
Reversed Phase
Polar-RP
HPLC
Anti-Inflammatory Agents, Non-Steroidal
Clinical
Pharmaceutical/Biopharmaceutical
Pharmaceutical
Therapeutic / Clinical

Applications

Analgesics on Synergi Polar-RP

Analytes

1
2
3
4
5
6
Compound Name
Ethylparaben
CID
8434
Molecular Formula
C9H10O3
Molecular Weight
166
No. Hydrogen Bond Acceptors
3
No. Hydrogen Bond Donors
1

Conditions

LC Conditions (App ID: 14250)
Column:Synergi 4 µm Polar-RP 80 Å, LC Column 150 x 4.6 mm, Ea
Brand Name:Synergi
Part No:00F-4336-E0
Elution Type:Isocratic
Mobile Phase:A: Acetonitrile
B: 20mM Potassium phosphate, pH 2.5
Gradient Profile:
Step No.Time(min)%A%B
105050
Flow Rate:1.5 mL/min
Temperature:22°C
Detection:UV-Vis Abs.-Variable Wave.(UV) nm @ 22°C

Order Items Used in This Application

Similar Applications
Kinetex 2.6 µm XB-C18 100 Å, LC Column 150 x 4.6 mm, Ea
Reversed Phase
Kinetex 2.6 µm C18 100 Å, LC Column 50 x 2.1 mm, Ea
Reversed Phase
Kinetex 2.6 µm C18 100 Å, LC Column 50 x 2.1 mm, Ea
Reversed Phase
Synergi 4 µm Fusion-RP 80 Å, LC Column 150 x 4.6 mm, Ea
Reversed Phase
Synergi 4 µm Hydro-RP 80 Å, LC Column 150 x 4.6 mm, Ea
Reversed Phase
Synergi 4 µm Polar-RP 80 Å, LC Column 150 x 4.6 mm, Ea
Reversed Phase
Synergi 4 µm Max-RP 80 Å, LC Column 150 x 4.6 mm, Ea
Reversed Phase
Gemini 5 µm C18 110 Å, LC Column 150 x 4.6 mm, Ea
Reversed Phase
Gemini 5 µm C18 110 Å, LC Column 150 x 4.6 mm, Ea
Reversed Phase
Gemini 5 µm C18 110 Å, LC Column 150 x 4.6 mm, Ea
Reversed Phase